People · Operator
Named in public records as an officer, director or promoter · active 2013–2019 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applied Stemcell Inc | — | Biotechnology | Series B | $23.5M | $754.1M | 2013 |
| Wearhaus Inc. | — | Other Technology | Series A | $4.0M | $111.8M | 2017 |
| Avirmax, Inc. | — | Biotechnology | Seed | $3.0M | $133.2M | 2019 |
Shengjiang Liu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shengjiang Liu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Curtis Mo | 1 | 8 |
| James Zhu | 1 | 4 |
| Guoliang Yu | 1 | 4 |
| Qianye Karen Liu | 1 | 2 |
| Yu Karen Fang | 1 | 1 |
| Haifeng Chen | 1 | 1 |
| Nancy Karen Chang | 1 | 1 |
| Yue Tang | 1 | 1 |
| Nelson Zhang | 1 | 1 |
| Richie Zeng | 1 | 1 |
| Zhenyu Xiao | 1 | 1 |
| Ruhong Jiang | 1 | 1 |
| Grace Tian | 1 | 1 |
| Dean Tsao | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.